Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 31, 2020Clinical and Translational ScienceOpen Access

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

View Full Paper
Ask AI
Bookmark
Share

Authors

KIKei IrieCincinnati Children's Hospital Medical CenterANAtsushi NakagawaKure Kyosai HospitalHFH. FujitaKobe City Medical Center General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Irie et al. (2020) studied this question.

synapsesocial.com/papers/6aaa2bb420cf838608fbd9aehttps://doi.org/10.1111/cts.12827
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1COVID-19 pandemic: perspectives on an unfolding crisis2020 · 883 citations
  2. 2Pharmacokinetics of Favipiravir during Continuous Venovenous Haemofiltration in a Critically ill Patient with Influenza2017 · 19 citations
  3. 3Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase2017 · 1,103 citations
  4. 4Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator‐associated pneumonia and evaluation of dosage regimens2014 · 44 citations